HIV & AIDS

Developing effective vaccines against SARS-CoV-2 and HIV

Researchers led by Raghavan Varadarajan, professor at the Molecular Biophysics Unit, Indian Institute of Science (IISc), are working toward developing effective vaccine strategies against two viruses: SARS-CoV-2 and HIV.

Vaccination

Will low-income countries miss out on the COVID-19 vaccine?

A new global assessment of purchasing agreements for COVID-19 vaccines reveals that high-income countries, as well as a few middle-income countries flush with manufacturing capacity, have already purchased nearly 3.8 billion ...

Vaccination

Vaccine innovation sparks hope, questions

Reports that one of the vaccines for COVID-19 has shown highly promising results are a ray of hope for a world in the shadow of surging virus cases.

Vaccination

UK expert sees multiple virus vaccines early next year

A leading scientific adviser to the British government said Tuesday he expects several coronavirus vaccines to have been approved by early 2021, allowing life to begin to return to normal.

Vaccination

Testing timeline: What's ahead for COVID-19 vaccines

Pfizer's surprising news that its COVID-19 vaccine might offer more protection than anticipated—an announcement right after a fraught U.S. presidential election campaign—is raising questions about exactly how the different ...

Diseases, Conditions, Syndromes

Vaccine shows promise against herpes virus

A genetically edited form of a herpes simplex virus—rewired to keep it from taking refuge in the nervous system and eluding an immune response—has outperformed a leading vaccine candidate in a new study from the University ...

Diseases, Conditions, Syndromes

Fighting Zika? Call in the T cells

Where Aedes mosquitoes fly, Zika virus may not be far behind. Although the explosive 2015-2016 Zika epidemics in the Americas are behind us, Zika may re-emerge, and "in many countries, Zika may be spreading in silence," says ...

Medical research

Ultrapotent COVID-19 vaccine candidate designed via computer

An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. Designed ...

page 14 from 40